Authors:
KOSMIDIS P
SKARLOS D
KOUROUSSIS C
BOUKIS C
BIANCO AR
LELLI G
DELLACUNA GR
SCHULLER J
CALLAGHAN R
OULIDAISSA D
Citation: P. Kosmidis et al., BENEFIT OF GRANOCYTE(R) (LENOGRASTIM) IN PATIENTS TREATED WITH CAMPTO(R) (CPT-11) IN 1ST OR 2ND LINE METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-RESULTS OF A PHASE-III MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 162-162
Authors:
VANVEEN HW
CALLAGHAN R
SOCENEANTU L
SARDINI A
KONINGS WN
HIGGINS CF
Citation: Hw. Vanveen et al., A BACTERIAL ANTIBIOTIC-RESISTANCE GENE THAT COMPLEMENTS THE HUMAN MULTIDRUG-RESISTANCE P-GLYCOPROTEIN GENE, Nature, 391(6664), 1998, pp. 291-295
Authors:
DALE IL
TUFFLEY W
CALLAGHAN R
HOLMES JA
MARTIN K
LUSCOMBE M
MISTRY P
RYDER H
STEWART AJ
CHARLTON P
TWENTYMAN PR
BEVAN P
Citation: Il. Dale et al., REVERSAL OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE BY XR9051, ANOVEL DIKETOPIPERAZINE DERIVATIVE, British Journal of Cancer, 78(7), 1998, pp. 885-892
Authors:
ROSENBERG MF
CALLAGHAN R
FORD RC
HIGGINS CF
Citation: Mf. Rosenberg et al., STRUCTURE OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN TO 2.5 NM RESOLUTION DETERMINED BY ELECTRON-MICROSCOPY AND IMAGE-ANALYSIS, The Journal of biological chemistry, 272(16), 1997, pp. 10685-10694
Authors:
MARTIN C
BERRIDGE G
HIGGINS CF
CALLAGHAN R
Citation: C. Martin et al., THE MULTIDRUG-RESISTANCE REVERSAL AGENT SR33557 AND MODULATION OF VINCA ALKALOID BINDING TO P-GLYCOPROTEIN BY AN ALLOSTERIC INTERACTION, British Journal of Pharmacology, 122(4), 1997, pp. 765-771
Authors:
CALLAGHAN R
BERRIDGE G
FERRY DR
HIGGINS CF
Citation: R. Callaghan et al., THE FUNCTIONAL PURIFICATION OF P-GLYCOPROTEIN IS DEPENDENT ON MAINTENANCE OF A LIPID-PROTEIN INTERFACE, Biochimica et biophysica acta. Biomembranes, 1328(2), 1997, pp. 109-124
Authors:
GOODFELLOW HR
SARDINI A
RUETZ S
CALLAGHAN R
GROS P
MCNAUGHTON PA
HIGGINS CF
Citation: Hr. Goodfellow et al., PROTEIN-KINASE C-MEDIATED PHOSPHORYLATION DOES NOT REGULATE DRUG TRANSPORT BY THE HUMAN MULTIDRUG-RESISTANCE P-GLYCOPROTEIN, The Journal of biological chemistry, 271(23), 1996, pp. 13668-13674
Citation: R. Callaghan et Jr. Riordan, OPIATES INHIBIT ION CONDUCTANCES ELICITED BY CELL SWELLING AND CAMP IN CULTURED-CELLS, European journal of pharmacology. Molecular pharmacology section, 291(2), 1995, pp. 183-189
Citation: R. Callaghan et Cf. Higgins, INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN, British Journal of Cancer, 71(2), 1995, pp. 294-299
Citation: R. Callaghan et Jr. Riordan, COLLATERAL SENSITIVITY OF MULTIDRUG-RESISTANT CELLS TO NARCOTIC ANALGESICS IS DUE TO EFFECTS ON THE PLASMA-MEMBRANE, Biochimica et biophysica acta. Biomembranes, 1236(1), 1995, pp. 155-162
Authors:
CALLAGHAN R
PAULL P
DESMOND PV
MASHFORD ML
Citation: R. Callaghan et al., FACTORS AFFECTING THE HEPATIC ELIMINATION OF OXIDIZED AND OF GLUCURONIDATED HIGH CLEARANCE DRUGS FOLLOWING ACUTE ADMINISTRATION OF CARBON-TETRACHLORIDE, Journal of hepatology, 20(6), 1994, pp. 742-749
Citation: R. Callaghan et Jr. Riordan, TRANSPORT OF NATURAL AND SYNTHETIC OPIATES BY MULTIDRUG RESISTANCE P-GLYCOPROTEIN, The FASEB journal, 7(7), 1993, pp. 1077-1077
Authors:
CALLAGHAN R
DESMOND PV
PAULL P
MASHFORD ML
Citation: R. Callaghan et al., HEPATIC ENZYME-ACTIVITY IS THE MAJOR FACTOR DETERMINING ELIMINATION RATE OF HIGH-CLEARANCE DRUGS IN CIRRHOSIS, Hepatology, 18(1), 1993, pp. 54-60
Citation: R. Callaghan et al., THE EFFECT OF A NUTRITIONAL MODEL OF CHRONIC LIVER-INJURY ON THE HEPATIC GLUCURONIDATION OF MORPHINE IN RATS, Journal of Pharmacy and Pharmacology, 45(11), 1993, pp. 998-999
Citation: R. Callaghan et Jr. Riordan, SYNTHETIC AND NATURAL OPIATES INTERACT WITH P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CELLS, The Journal of biological chemistry, 268(21), 1993, pp. 16059-16064